Biotechnology
News Category
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech AG appoints Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor cancer therapies, signaling a strategic pu...
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for BiTAC®-TCE Program
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead BiTAC®-TCE candid...
Onco-Innovations Advances Precision Oncology with ONC010 as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations Ltd. is advancing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the shift toward p...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma (NASDAQ: LTRN) received a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for its investiga...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech AG has appointed Christoph Erkel as CSO to lead the development of its BiTAC platform for solid tumor cancer therapies, leveraging his ...
iOrganBio Appoints Lee L. Rubin, Ph.D. to Scientific Advisory Board, Strengthening Neurological Disease Focus
iOrganBio expands its Scientific Advisory Board with stem cell and neuroscience expert Lee L. Rubin, Ph.D., aiming to enhance its CellForge platform f...
BioAdaptives Completes Manufacturing Readiness for Wellness Product Launch
BioAdaptives has finalized commercial manufacturing and logistics for its MyndSystem and Xcellara platforms, targeting the cognitive and cellular well...
Creative Biolabs Expands Microfluidics Solutions to Accelerate High-Throughput Antibody Discovery
Creative Biolabs expands its integrated microfluidics portfolio to enhance high-throughput antibody discovery by improving screening throughput, assay...
Quantum BioPharma Targets Brain Disorders with Dual-Pronged Pipeline
Quantum BioPharma is advancing a two-pronged approach to address multiple sclerosis and alcohol intoxication, with its lead candidate Lucid-MS enterin...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Cancer Therapy Sapu003
Oncotelic Therapeutics announced the publication of preclinical data for its intravenous everolimus formulation Sapu003, which could overcome oral dru...
Kairos Pharma and Bayer Collaborate to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma has partnered with Bayer to test its antibody ENV-105 with XOFIGO in metastatic castration-resistant prostate cancer, potentially offeri...
VERAXA Biotech Advances BiTAC-TCE Program with Positive Regulatory Feedback from German PEI
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its BiTAC-TCE development, reducing uncertainty before ...
VivoSim Labs Raises $4 Million in Private Placement with Healthcare-Focused Institutional Investor
VivoSim Labs raised $4 million through a private placement, issuing shares and warrants to a healthcare-focused institutional investor, with proceeds ...
Greenwich LifeSciences Advances Phase 3 Trial for Breast Cancer Immunotherapy GLSI-100
Greenwich LifeSciences reported that its Phase 3 FLAMINGO-01 trial for GLSI-100 continues without modification after a DSMB review, with plans to expa...
Quantum BioPharma Develops Two-Pronged Strategy to Address Unmet Needs in Neurological Disorders
Quantum BioPharma is advancing a pipeline targeting multiple sclerosis with its novel therapy Lucid-MS and alcohol intoxication effects with its suppl...
American Fusion Secures Texas Certificate of Registration for Texatron Fusion Engine Testing
American Fusion Inc. has obtained a Texas DSHS Certificate of Registration, enabling R&D activities for its Texatron Fusion Engine at Texas Tech Unive...
WHO-Commissioned Study Finds No Evidence Linking Mobile Phones to Brain Cancer
A comprehensive review commissioned by the World Health Organization found no evidence that mobile phone use causes brain cancer, addressing long-stan...
Quantum BioPharma Hits Key Study Milestone as Early MS Imaging Data Shows Promising Signal
Quantum BioPharma announced that its imaging study for multiple sclerosis has reached halfway patient enrollment, with preliminary data showing encour...
GeoVax Highlights Alignment of GEO-MVA Platform with HHS/ASPR's Five-Year Biodefense Strategy
GeoVax's GEO-MVA vaccine platform aligns with the HHS/ASPR's five-year medical countermeasure strategy that prioritizes domestic manufacturing, platfo...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute, providing clarity on the development strategy for its proprietary...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform, Advancing Toward Clinical Development
VERAXA Biotech AG announced positive regulatory feedback from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on develo...
Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials announced Japan patent allowance for its GelrinC manufacturing technology, strengthening its IP portfolio and position in the gr...
MindBio Therapeutics Advances Voice-Based AI Tech for Real-Time Impairment Detection
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect drug and alcohol impairment in real-time, targeting workplace safet...
Gut Microbiome Metabolites Linked to Improved Cancer Immunotherapy Response
New research identifies gut microbial metabolites that enhance cancer immunotherapy efficacy, offering potential biomarkers and therapeutic targets to...
SS Innovations Appoints Veteran Medtech Finance Executive as CFO Amid Global Expansion and FDA Pursuit
SS Innovations International appoints Sarah M. Romano as CFO to bolster financial leadership as it advances FDA clearance for its SSi Mantra surgical ...
Creative Biolabs Unveils Integrated Microfluidics and Electrochemical Biosensor Platform for POCT
Creative Biolabs combines microfluidics and electrochemical biosensors to accelerate the development of next-generation point-of-care diagnostics, ena...
BioAdaptives Details Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives outlines its Xcellara platform strategy, combining a stem cell mobilization base with tissue-specific ingredients, ahead of the August 1 ...
NeuroOne Expands Drug Delivery Platform via Collaboration with Mayo Clinic on Pediatric Brain Cancer Trial
NeuroOne Medical Technologies partners with Mayo Clinic in a Children's Cancer Research Fund-supported clinical trial to evaluate a novel drug deliver...
Oncotelic Therapeutics Launches AI-Powered GMP Manufacturing Platform to Support Biotech Industry
Oncotelic Therapeutics introduced an AI and robotics-driven manufacturing platform that aims to help emerging biotech companies access full GMP infras...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma is progressing its novel multiple sclerosis therapy LUCID-MS, which targets myelin repair, into Phase 2 clinical trials after demons...
VERAXA Biotech Leverages AI Partnership to Advance BiTAC(R) Oncology Platform
VERAXA Biotech's collaboration with AI firm Ardigen aims to enhance its BiTAC(R) cancer therapy platform through AI-enabled target discovery, position...
Tonix Pharmaceuticals Publishes Mpox Research Supporting TNX-801 Vaccine Development
New preclinical research published in the Journal of Virology shows that the current mpox clade IIb strain is up to 100,000 times less virulent than h...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Drug Pipeline
Nuvectis Pharma announced the pricing of a $100 million underwritten public offering to fund the development of its NXP100, NXP200, and NXP900 program...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced no Grade 3 or higher adverse events in 13 patients treated with ENV-105 plus osimertinib, supporting continued development to ...
NeuroThera Labs Initiates Phase IIb Trial of SCI-110 for Tourette Syndrome at Hannover Medical School
NeuroThera Labs has started its Phase IIb clinical trial for SCI-110, a cannabinoid-based treatment for Tourette Syndrome, at Hannover Medical School ...
Earth Science Tech Inc. Leverages Technology and Strategic Positioning to Expand Market Share in Telehealth and Peptide Therapies
Earth Science Tech Inc. (ETST) is capitalizing on the growing telehealth and peptide therapy markets through its proprietary technology and vertical i...
Formycon and OneSource Forge Strategic Biosimilar Manufacturing Partnership
Formycon AG partners with OneSource Specialty Pharma to leverage India-based manufacturing for cost-efficient, scalable biosimilar production, aiming ...
Quantum BioPharma Advances LUCID-MS Toward Phase 2 Trial for Multiple Sclerosis
Quantum BioPharma's LUCID-MS, a neuroprotective therapy targeting myelin repair in multiple sclerosis, shows favorable safety in Phase 1 and is advanc...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma's proprietary MS therapy LUCID-MS, designed to protect and restore myelin, shows favorable safety in Phase 1 and moves toward Phase ...
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program to Accelerate AI Agent Platform Development
Silo Pharma's subsidiary QwikAgents gains access to AMD Developer Cloud credits and AI tools through the AMD AI Developer Program, aiming to enhance i...
VERAXA Biotech Leverages AI Partnership to Advance BiTAC(R) Cancer Therapy Platform
VERAXA Biotech's collaboration with AI-focused Ardigen aims to enhance target discovery for its BiTAC(R) platform, reflecting a broader industry trend...
DN Group AG Subsidiary Algene Achieves First Harvest of High-Purity Microalgae, Launching Series Production
Algene Holding SE, a subsidiary of DN Group AG, successfully harvested 4,500 liters of high-purity microalgae, marking the start of series production ...
VERAXA Biotech Partners with Ardigen to Enhance AI-Driven Cancer Drug Development
VERAXA Biotech collaborates with Ardigen to integrate AI into its BiTAC pipeline, aiming to improve target selection and reduce toxicity in oncology d...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides gains ethics committee approval in the DRC for a Phase II trial of NV-387 oral gummies against ebolavirus, potentially offering the firs...
Tonix Pharmaceuticals Expands TONMYA Medicare Coverage to 145 Million Lives
Tonix Pharmaceuticals announced a major managed Medicare agreement for TONMYA, adding 9 million Medicare beneficiaries and expanding total pharmacy co...
VERAXA Biotech Partners with Ardigen to Integrate AI into Cancer Drug Development
VERAXA Biotech AG collaborates with Ardigen to leverage AI for advancing its BiTAC pipeline, aiming to improve target selection and reduce toxicity in...
Onco-Innovations Completes Reference Standard Program for Lead Cancer Drug
Onco-Innovations announced the successful completion of an analytical reference standard program for its lead oncology candidate ONC010, a key step to...
VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Permanent Search
VERAXA Biotech AG has named Carl von Halem interim CFO to lead financial operations during a transition, as the company finalizes a permanent replacem...